Inventor · disambiguated record
Jenny Viklund
Also filed as: VIKLUND JENNY
15 granted patents·13 pending applications·14 citations·filing 2005–2023
87Inventor score
Top patents by PatentIndex Score
28 records- 0193US11633403B26-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetesSPRINT BIOSCIENCE AB·Filed 2021·Granted Apr 25, 2023·3 cites·20 claims
- 0287US11208423B2Pyridinamine-pyridone and pyrimidinamine- pyridone compoundsSPRINT BIOSCIENCE AB·Filed 2018·Granted Dec 28, 2021·3 cites·17 claims
- 0384US11179399B26-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetesSPRINT BIOSCIENCE AB·Filed 2017·Granted Nov 23, 2021·3 cites·36 claims
- 0478US11667651B2Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2018·Granted Jun 6, 2023·1 cites·11 claims
- 0577US11219618B2Pyridylpyridone compoundsSPRINT BIOSCIENCE AB·Filed 2018·Granted Jan 11, 2022·2 cites·17 claims
- 0673US2024050439A16-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetesSpring Bioscience AB·Filed 2023·Application pending·0 cites
- 0770US2024158415A1Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2023·Application pending·0 cites
- 0869US2023234949A1Morpholinylpyridone compoundsSPRINT BIOSCIENCE AB·Filed 2022·Application pending·0 cites
- 0968US11780858B2Pyridinamine-pyridone and pyrimidinamine-pyridone compoundsSPRINT BIOSCIENCE AB·Filed 2021·Granted Oct 10, 2023·0 cites·17 claims
- 1068US2023322772A1Azaindolylpyridone and diazaindolylpyridone compoundsSPRINT BIOSCIENCE AB·Filed 2022·Application pending·0 cites
- 1165US11963963B26-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetesSPRINT BIOSCIENCE AB·Filed 2021·Granted Apr 23, 2024·0 cites·20 claims
- 1265US9650336B2Mono-fluoro beta-secretase inhibitorsASTRAZENECA AB·Filed 2012·Granted May 16, 2017·1 cites·16 claims
- 1362US11560374B2Morpholinylpyridone compoundsSPRINT BIOSCIENCE AB·Filed 2018·Granted Jan 24, 2023·0 cites·17 claims
- 1462US9145380B2Bis-(sulfonylamino) derivatives for use in therapyBYLUND JOHAN·Filed 2008·Granted Sep 29, 2015·1 cites·14 claims
- 1562US2022218688A1Pyridylpyridone compoundsSPRINT BIOSCIENCE AB·Filed 2021·Application pending·0 cites
- 1661US11498919B2Azaindolylpyridone and diazaindolylpyridone compoundsSPRINT BIOSCIENCE AB·Filed 2018·Granted Nov 15, 2022·0 cites·17 claims
- 1759US11077113B26-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetesSPRINT BIOSCIENCE AB·Filed 2017·Granted Aug 3, 2021·0 cites·23 claims
- 1856US2011021540A1Bis-(Sulfonylamino) Derivatives in Therapy 066ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1956US2009281138A1Bis-(Sulfonylamino) Derivatives in Therapy 066ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2053US2009163586A1Bis-(Sulfonylamino) Derivatives in Therapy 205ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2148US2009131468A1Bis-(Sulfonylamino) Derivatives in Therapy 065ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2245US8026244B2Thioxanthine derivatives and their use as inhibitors of MPOASTRAZENECA AB·Filed 2007·Granted Sep 27, 2011·0 cites·7 claims
- 2343US11584763B2Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2018·Granted Feb 21, 2023·0 cites·16 claims
- 2443US2009286813A1Thioxanthine Derivatives and Their Use as Inhibitors of MPOASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2541US2008096929A1Novel UseASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2640US11919902B2Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2018·Granted Mar 5, 2024·0 cites·13 claims
- 2738US2011098292A1New Compounds Useful for Treating CNS DisordersASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2836US2009192190A1Benzoic Acid Derivatives that are Modulators or Agonists of GlyRGYBACK HELENA·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →